)
Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
glp 1 receptor agonist weight loss GLP-1 agonists for reduction in people living with obesity but without diabetes: a living benefit–harm modelling study Type:Ebook + Audiobook Bundle New oral GLP-1 drug energy-support
New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks
New Formulations: Efforts are underway to create more convenient formulations, including longer-acting injectables that may only require monthly administration and improved oral versions
energy-support
Type:Ebook + Audiobook Bundle
September 2025: Pfizer announced its agreement to acquire Metsera in a deal valued at up to USD 7.3 billion, strengthening its pipeline of next-generation GLP-1, amylin, and obesity therapies
US$ 27.46
US$ 26.21
US$ 20.04
